CRP and cancer: Biomarkers of inflammation, such as C-reactive protein (CRP), neutrophil count (NC), and neutrophil-to-lymphocyte ratio (NLR), have been studied as important tools for risk stratification in cancers associated with increased tumor burden and aggressive tumor biology [5–7].